3-(4-甲基苯基)-3-(三氟甲基)双吖丙啶合成路线 (共 9 条)
反应条件
1: 58 percent / KMnO4 / pyridine; H2O / 20 h / 50 °C 2: 73 percent / N,N'-dicyclohexylcarbodiimide / dioxane; ethyl acetate / 6 h / Ambient temperature View Scheme
参考文献
Liebigs Annalen der Chemie, , # 9 p. 1510 - 1523
反应条件
1: 38 percent / KMnO4 / pyridine 2: 95 percent / cyanuric fluoride, pyridine / CH2Cl2 / 2 h / -20 - -10 °C 3: 84 percent / LiBH4 / tetrahydrofuran; methanol / 1 h / Ambient temperature View Scheme
参考文献
Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 41, # 3 p. 191 - 199
反应条件
potassium permanganate in pyridine; water T=50°C; 20 h;
参考文献
Nassal, Michael
Liebigs Annalen der Chemie, 1983 , # 9 p. 1510 - 1523
反应条件
silver(l) oxide in diethyl ether
1 h;
参考文献
Nassal, Michael
Liebigs Annalen der Chemie, 1983 , # 9 p. 1510 - 1523
反应条件
1: hydroxylamine
2: pyridine
3: NH3 (liquid)
4: I2; Et3N
View Scheme
参考文献
Wei, Shuai; Wang, Jing; Guo, Dong-Jie; Chen, Ya-Qing; Xiao, Shou-Jun
Chemistry Letters, 2006 , vol. 35, # 10 p. 1172 - 1173
反应条件
1: pyridine
2: NH3 (liquid)
3: I2; Et3N
View Scheme
参考文献
Wei, Shuai; Wang, Jing; Guo, Dong-Jie; Chen, Ya-Qing; Xiao, Shou-Jun
Chemistry Letters, 2006 , vol. 35, # 10 p. 1172 - 1173
反应条件
1: NH3 (liquid)
2: I2; Et3N
View Scheme
参考文献
Wei, Shuai; Wang, Jing; Guo, Dong-Jie; Chen, Ya-Qing; Xiao, Shou-Jun
Chemistry Letters, 2006 , vol. 35, # 10 p. 1172 - 1173
反应条件
1.1: n-BuLi / diethyl ether; hexane / 2 h / -40 - 0 °C
1.2: 54 percent / diethyl ether; hexane / 3 h / -60 °C
2.1: hydroxylamine hydrochloride; pyridine / 3 h / 70 °C
3.1: 2.90 g / pyridine / 3 h / Heating
4.1: 77 percent / NH3 / diethyl ether / 12 h / 20 °C
5.1: 82 percent / I2; Et3N / CH2Cl2
View Scheme
参考文献
Stromgaard, Kristian; Saito, D. Roland; Shindou, Hideo; Ishii, Satoshi; Shimizu, Takao; Nakanishi, Koji
Journal of Medicinal Chemistry, 2002 , vol. 45, # 18 p. 4038 - 4046
反应条件
N-bromosuccinmide; dibenzoyl peroxide in tetrachloromethane
T=70°C; 3 h;
参考文献
Latli, Bachir; Morimoto, Hiromi; Williams, Philip G.; Casida, John E.
Journal of Labelled Compounds and Radiopharmaceuticals, 1998 , vol. 41, # 3 p. 191 - 199